Finding 1151331 (2024-005)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2024
Accepted
2025-08-28
Audit: 365147
Auditor: Terry Horne CPA

AI Summary

  • Core Issue: The Organization failed to verify that employees and vendors were not suspended or debarred from federal programs before transactions.
  • Impacted Requirements: This finding violates procurement regulations outlined in 45 CFR 75.329 and 45 CFR 75.213.
  • Recommended Follow-Up: Establish and document policies to ensure debarment searches are conducted and procurement policies are followed.

Finding Text

Finding: 2024-005 Procurement, Suspension, and Debarment Federal Programs: Department of Health and Human Services Health Center Program Cluster Assistance Listing No. - 93.527 & 93.224 Criteria: Procurement 45 CFR 75.329 and 45 CFR 75.213 Condition: The Organization did not verify that employees and certain vendors were not suspended, debarred, or otherwise excluded from participating in federal programs before entering into transactions with them. Cause: The Organization did not have proper procedures in place to ensure debarment searches were obtained as required. Effect: The Organization did not verify that employees and certain vendors were not suspended, debarred, or otherwise excluded from participating in federal programs before entering into transactions with them. Questioned Costs: None reported. Context/Sampling: The finding appears to be a systemic issue. Repeat Finding from Prior Year: Yes Recommendation: It is recommended that the Organization establish policies and procedures to ensure that the procurement policy is followed and that debarment searches are performed and documented as required. Views of Responsible Officials: Management concurs. This was corrected after the audit for the fiscal year ended November 30, 2023, which was completed after the fiscal year ended November 30, 2024. Contact Person: Suzanne Freeman, CEO Anticipated Date of Completion: October 31, 2025

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 574884 2024-004
    Material Weakness Repeat
  • 574885 2024-004
    Material Weakness Repeat
  • 574886 2024-004
    Material Weakness Repeat
  • 574887 2024-004
    Material Weakness Repeat
  • 574888 2024-005
    Material Weakness Repeat
  • 574889 2024-005
    Material Weakness Repeat
  • 574890 2024-005
    Material Weakness Repeat
  • 574891 2024-005
    Material Weakness Repeat
  • 574892 2024-006
    Material Weakness Repeat
  • 574893 2024-006
    Material Weakness Repeat
  • 574894 2024-006
    Material Weakness Repeat
  • 574895 2024-006
    Material Weakness Repeat
  • 574896 2024-007
    Material Weakness
  • 574897 2024-007
    Material Weakness
  • 574898 2024-007
    Material Weakness
  • 574899 2024-007
    Material Weakness
  • 1151326 2024-004
    Material Weakness Repeat
  • 1151327 2024-004
    Material Weakness Repeat
  • 1151328 2024-004
    Material Weakness Repeat
  • 1151329 2024-004
    Material Weakness Repeat
  • 1151330 2024-005
    Material Weakness Repeat
  • 1151332 2024-005
    Material Weakness Repeat
  • 1151333 2024-005
    Material Weakness Repeat
  • 1151334 2024-006
    Material Weakness Repeat
  • 1151335 2024-006
    Material Weakness Repeat
  • 1151336 2024-006
    Material Weakness Repeat
  • 1151337 2024-006
    Material Weakness Repeat
  • 1151338 2024-007
    Material Weakness
  • 1151339 2024-007
    Material Weakness
  • 1151340 2024-007
    Material Weakness
  • 1151341 2024-007
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $2.21M
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $214,399
93.959 Block Grants for Prevention and Treatment of Substance Abuse $81,523
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $79,797
16.838 Comprehensive Opioid Abuse Site-Based Program $68,116
93.988 Cooperative Agreements for State-Based Diabetes Control Programs and Evaluation of Surveillance Systems $12,148